Controlling the Pharmaceutical Industry
AJ explains how the PBM industry created a pay-to-play economic scenario through formularies and rebate dollars. He highlights the inelastic demand curve of the pharmaceutical industry and the compounding effect of high-cost therapies. AJ emphasizes the lack of competition and the need for innovation in this industry.In this clip
From this podcast
This Week in Startups
Solving prescription drug pricing in the US with Cost Plus Drugs & Capital RX CEOs | E1518
Related Questions